Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: Protocol for a phase 2, randomised, double-blind, placebo-controlled trial

Lucy Vivash, Kelly Bertram, Charles B. Malpas, Cassandra Marotta, Ian Harding, Scott Kolbe, Joanne Fielding, Meaghan Clough, Simon John Geoffrey Lewis, Stephen Tisch, Andrew H. Evans, John D O'Sullivan, Thomas E Kimber, David G. Darby, Leonid Churilov, Meng Law, Christopher M Hovens, Dennis Velakoulis, Terence John O'Brien

Research output: Contribution to journal › Article › Other › peer-review

4 Citations (Scopus)

2 results

Active

Sodium Selenate as a Disease Modifying Treatment for Progressive Supranuclear Palsy (Sodium Selenate for PSP)
O'Brien, T., Bertram, K., Vivash, L., Evans, A. H., Kimber, T. E., O'Sullivan, J. D., Malpas, C., Fielding, J., Velakoulis, D. & Law, M.
1/06/20 → 31/05/25
Project: Research
Developing new treatments and identifying biomarkers to enable transformational, precision medicine based care for patients with drug resistant epilepsy
O'Brien, T.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/20 → 31/12/24
Project: Research